| Dr Kevin Allen Ross, MD | |
|
221 5th Ave S, Glasgow, MT 59230-2600 | |
| (406) 228-3400 | |
| (406) 228-3413 |
| Full Name | Dr Kevin Allen Ross |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 221 5th Ave S, Glasgow, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649572355 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD61106394 (Washington) | Secondary |
| 207Q00000X | Family Medicine | 18924 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Frances Mahon Deaconess Hospital | Glasgow, MT | Hospital |
| Phillips County Hospital - Cah | Malta, MT | Hospital |
| Billings Clinic | Billings, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Frances Mahon Deaconess Hospital | 3173430949 | 35 |
News Archive
Emergency room staff call it a "pop drop" - when a disabled older person comes in for medical attention, but it seems like the person who takes care of them at home is also seeking a break from the demands of caregiving.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used to help set priorities related to kidney care and to increase public interest in the prevention of kidney disease.
St. George's University recently participated in a groundbreaking feasibility study for an infectious disease surveillance system conducted with a team of researchers and scientists in Grenada.
› Verified 2 days ago
| Entity Name | Frances Mahon Deaconess Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639117013 PECOS PAC ID: 3173430949 Enrollment ID: O20031111000918 |
News Archive
Emergency room staff call it a "pop drop" - when a disabled older person comes in for medical attention, but it seems like the person who takes care of them at home is also seeking a break from the demands of caregiving.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used to help set priorities related to kidney care and to increase public interest in the prevention of kidney disease.
St. George's University recently participated in a groundbreaking feasibility study for an infectious disease surveillance system conducted with a team of researchers and scientists in Grenada.
› Verified 2 days ago
| Entity Name | Daniels Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750459632 PECOS PAC ID: 4880685965 Enrollment ID: O20040518001546 |
News Archive
Emergency room staff call it a "pop drop" - when a disabled older person comes in for medical attention, but it seems like the person who takes care of them at home is also seeking a break from the demands of caregiving.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used to help set priorities related to kidney care and to increase public interest in the prevention of kidney disease.
St. George's University recently participated in a groundbreaking feasibility study for an infectious disease surveillance system conducted with a team of researchers and scientists in Grenada.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Allen Ross, MD 221 5th Ave S, Glasgow, MT 59230-2600 Ph: (406) 228-3400 | Dr Kevin Allen Ross, MD 221 5th Ave S, Glasgow, MT 59230-2600 Ph: (406) 228-3400 |
News Archive
Emergency room staff call it a "pop drop" - when a disabled older person comes in for medical attention, but it seems like the person who takes care of them at home is also seeking a break from the demands of caregiving.
CoDa Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics for wound care and tissue repair, today announced positive results from its Phase 2 NOVEL Study of NEXAGON® in patients with chronic venous leg ulcers. NEXAGON® is a topically applied, novel therapeutic candidate, with the potential to revolutionize the wound healing treatment paradigm by leveraging a new mechanism and target involved in the healing process.
How likely are middle-aged adults to develop kidney failure during their lifetime? A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides some insights, which may be used to help set priorities related to kidney care and to increase public interest in the prevention of kidney disease.
St. George's University recently participated in a groundbreaking feasibility study for an infectious disease surveillance system conducted with a team of researchers and scientists in Grenada.
› Verified 2 days ago
Michelle Ozark, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 4th Ave S, Glasgow, MT 59230 Phone: 406-698-0162 | |
David Arthur Knierim, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 5th Ave S, Glasgow, MT 59230 Phone: 406-228-3400 Fax: 406-228-3413 | |
Gordon L Bell, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 221 5th Ave S, Glasgow, MT 59230 Phone: 406-228-3400 | |
Dr. Anne M Millard, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 221 5th Ave S, Glasgow, MT 59230 Phone: 406-228-3400 |